Werewolf Therapeutics, Inc. (HOWL) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.92HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
MBOT
Microbot Medical Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — HOWL vs MBOT
growth of $100 · dividends reinvested · last 5yHOWL -94.2% (-43.5%/yr)MBOT -86.2% (-32.7%/yr)MBOT compounded faster over this window
HOWL MBOT
HOWL vs MBOT: by the numbers
- •MBOT is the larger company ($50M vs $45M market cap).
- •Both run net losses; HOWL's is the smaller (-164.82% vs -4722.25% net margin).
Metrics side by side
Valuation
| Metric | HOWL | MBOT |
|---|---|---|
| P/S ratio | 2.13 | 144.22 |
| P/B ratio | 2.75 | 0.72 |
Profitability
| Metric | HOWL | MBOT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -164.82% | -4722.25% |
| ROE | -212.45% | -23.70% |
| ROIC | -156.97% | -26.51% |
Growth (annualized)
| Metric | HOWL | MBOT |
|---|---|---|
| Total return CAGR (5Y) | -44.27% | -31.63% |
Frequently asked
- How have HOWL and MBOT total returns compared?
- Over the past 5 years, HOWL delivered -44.27% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.